Log In Sign up
The largest database of trusted experimental protocols

Cd29 pacblue

Manufactured by BD
Visit Supplier

CD29-PacBlue is a fluorophore-conjugated antibody that binds to the CD29 cell surface protein. CD29, also known as integrin beta-1, is a widely expressed cell adhesion molecule involved in various cellular processes. The PacBlue fluorescent dye attached to the CD29 antibody allows for the detection and analysis of CD29-expressing cells using flow cytometry or other fluorescence-based techniques.

Automatically generated - may contain errors

Lab products found in correlation

Cd24 pe cy7, by BD (2 mentions) Annexin 5 pacblue, by BD (2 mentions) Lineage cocktail, by BD (2 mentions)

2 protocols using cd29 pacblue

1

Phenotypic Analysis of Single Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cells were labeled with antibodies for CD24-PeCy7 and CD29-PacBlue, or Annexin V-PacBlue (BD Pharmingen), based on the manufacturer’s data sheet. Lineage cells were excluded using the BD Pharmingen lineage cocktail. Dead cells were excluded by staining with Sytox Red (1:1000).
Knezevic J., Pfefferle A.D., Petrovic I., Greene S.B., Perou C.M, & Rosen J.M. (2015). Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene, 34(49), 5997-6006.
+ Open protocol
+ Expand
2

Phenotypic Analysis of Single Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cells were labeled with antibodies for CD24-PeCy7 and CD29-PacBlue, or Annexin V-PacBlue (BD Pharmingen), based on the manufacturer’s data sheet. Lineage cells were excluded using the BD Pharmingen lineage cocktail. Dead cells were excluded by staining with Sytox Red (1:1000).
Knezevic J., Pfefferle A.D., Petrovic I., Greene S.B., Perou C.M, & Rosen J.M. (2015). Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene, 34(49), 5997-6006.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!